- CA$3.74bn
- CA$5.18bn
- CA$2.50bn
- 55
- 92
- 58
- 77
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Total Premiums Earned | |||||
Net Investment Income | |||||
Realized & Unrealized Gains / Losses | |||||
Other Revenue | |||||
Total Revenue | 1,664 | 1,600 | 1,651 | 569 | 2,501 |
Losses, Benefits, and Adjustments | |||||
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,886 | 1,802 | 953 | 1,130 | 1,226 |
Operating Profit | -222 | -201 | 697 | -561 | 1,274 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 1,027 | 713 | 1,497 | -561 | 1,274 |
Provision for Income Taxes | |||||
Net Income After Taxes | 862 | 604 | 1,282 | -478 | 1,095 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 748 | 504 | 1,166 | -331 | 955 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 729 | 484 | 1,137 | -326 | 933 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 168 | 116 | 281 | -91.7 | 245 |
Dividends per Share | |||||
Special Dividends per Share |